Literature DB >> 27720003

Epidemiology of Parkinson Disease.

Andrea Lee1, Rebecca M Gilbert2.   

Abstract

Parkinson disease (PD) is a common progressive neurodegenerative condition, causing both motor and non motor symptoms. Motor symptoms include stiffness, slowness, rest tremor and poor postural reflexes, whereas nonmotor symptoms include abnormalities of mood, cognition, sleep and autonomic function. Affected patients show cell loss in the substantia nigra pars compacta, and accumulation of aggregated alpha-synuclein into intracellular structures called Lewy bodies, within specific brain regions. The main known non modifiable risk factor is age. The neuroepidemiology of PD is complex with susceptibility genes and a number of modifiable risk factors that can increase and others that can mitigate risk and outcome.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Neurodegenerative disorder; Neuroepidemiology; Parkinson disease

Mesh:

Year:  2016        PMID: 27720003     DOI: 10.1016/j.ncl.2016.06.012

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  85 in total

1.  Downregulation of DEC1 contributes to the neurotoxicity induced by MPP+ by suppressing PI3K/Akt/GSK3β pathway.

Authors:  Zhu Zhu; Yu-Wen Wang; Ding-Hao Ge; Ming Lu; Wei Liu; Jing Xiong; Gang Hu; Xiao-Ping Li; Jian Yang
Journal:  CNS Neurosci Ther       Date:  2017-07-21       Impact factor: 5.243

Review 2.  Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy.

Authors:  Fauzia Nazam; Sibhghatulla Shaikh; Nazia Nazam; Abdulaziz Saad Alshahrani; Gulam Mustafa Hasan; Md Imtaiyaz Hassan
Journal:  Mol Cell Biochem       Date:  2021-03-09       Impact factor: 3.396

3.  Speech-based characterization of dopamine replacement therapy in people with Parkinson's disease.

Authors:  R Norel; C Agurto; S Heisig; J J Rice; H Zhang; R Ostrand; P W Wacnik; B K Ho; V L Ramos; G A Cecchi
Journal:  NPJ Parkinsons Dis       Date:  2020-06-12

Review 4.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

5.  The epidemiology of Parkinson's disease in the Italian region Friuli Venezia Giulia: a population-based study with administrative data.

Authors:  Francesca Valent; Grazia Devigili; Sara Rinaldo; Stefania Del Zotto; Annarita Tullio; Roberto Eleopra
Journal:  Neurol Sci       Date:  2018-02-09       Impact factor: 3.307

Review 6.  Sex differences in sleep apnea and comorbid neurodegenerative diseases.

Authors:  Brina Snyder; Rebecca L Cunningham
Journal:  Steroids       Date:  2017-12-16       Impact factor: 2.668

7.  Sudden unexpected death in Parkinson's disease (SUDPAR): sleep apnea increases risk of heart attack.

Authors:  Fulvio A Scorza; Sergio Tufik; Carla A Scorza; Monica Levy Andersen; Esper A Cavalheiro
Journal:  Sleep Breath       Date:  2017-05-23       Impact factor: 2.816

8.  The influences of behavioral and psychological interventions on the neurological function and MMSE scores in Parkinson's disease patients.

Authors:  Aimin Luo; Shuming Zhong; Shunkai Lai; Yanbin Jia
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

9.  MitoNEET (CISD1) Knockout Mice Show Signs of Striatal Mitochondrial Dysfunction and a Parkinson's Disease Phenotype.

Authors:  Werner J Geldenhuys; Stanley A Benkovic; Li Lin; Heather M Yonutas; Samuel D Crish; Patrick G Sullivan; Altaf S Darvesh; Candice M Brown; Jason R Richardson
Journal:  ACS Chem Neurosci       Date:  2017-09-27       Impact factor: 4.418

10.  Decreased serum proNGF concentration in patients with Parkinson's disease.

Authors:  Xiao-Min Xu; Mei-Xue Dong; Xia Feng; Yang Liu; Jun-Xi Pan; Shi-Yu Jia; Du Cao; You-Dong Wei
Journal:  Neurol Sci       Date:  2017-10-19       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.